MARC Record from marc_columbia

LEADER: 15499cam a22004454a 4500
001 6303121
005 20221122020851.0
008 070530t20082008paua b 001 0 eng
010 $a 2007022710
016 7 $a101308143$2DNLM
019 $a148858975
020 $a9780781779067
020 $a0781779065
029 1 $aNLM$b101308143
035 $a(OCoLC)ocn140105567
035 $a(OCoLC)140105567$z(OCoLC)148858975
035 $a(NNC)6303121
035 $a6303121
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dYDXCP$dC#P$dBWX$dOrLoB-B
042 $apcc
050 00 $aRC346$b.I53 2008
060 10 $aWL 340$bI602 2008
082 00 $a616.8$222
245 04 $aThe interface of neurology & internal medicine /$ceditor-in-chief, José Biller.
246 3 $aInterface of neurology and internal medicine
260 $aPhiladelphia :$bWolters Kluwer Health/Lippincott Wiliams & Wilkins,$c[2008], ©2008.
300 $axxix, 1021 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tCardiac manifestations of neurological disorders /$rBetsy B. Love, Jose Biller and David J. Wilber -- $g2.$tNeurologic manifestations of congenital heart disease /$rRobert Liehtenberg and David C. Anderson -- $g3.$tAcquired valvular heart disease /$rFred Leya -- $g4.$tInfective endocarditis /$rMinerva A. Galang and J. Paul O'Keefe -- $g5.$tCoronary artery disease /$rFred Leya -- $g6.$tHeart failure /$rCandice K. Sech, Alain Heroux and Jose Biller -- $g7.$tCardiomyopathies and other myocardial diseases /$rAmytis Towfight, Latisha K. Ali, Alain Heroux and Jeffrey L. Saver -- $g8.$tCardiac arrhythmias /$rWilliam H. Spear and David J. Wilber -- $g9.$tHypertension and hypertensive encephalopathy /$rDavid C. Bonovich -- $g10.$tOrthostatic and postprandial hypotension /$rEduardo E. Benarroch -- $g11.$tCoronary artery bypass surgery /$rJames D. Fleck and Jose Biller -- $g12.$tOther cardiovascular surgical/endovascular procedures /$rRichard A. Bernstein and Michael J. Schneck -- $g13.$tAtrial myxomas /$rLaurie E. Knepper and William Levy -- $g14.$tNeurological sequelae of cardiac transplantation /$rBeth K. Rush, Daniel S. Yip and James F. Meschia -- $g15.$tAortic diseases /$rCandice K. Sech, Jose Biller, Alain Heroux and Jeffrey Schwartz -- $g16.$tCommonly used cardiovascular drugs /$rLisa M. Hurst and Mark A. Ross -- $g17.$tAcute and chronic respiratory failure /$rLisa F. Wolfe and Senda Ajroud-Driss -- $g18.$tChronic obstructive pulmonary disease /$rThomas C. Corbridge and Richard A. Bernstein -- $g19.$tPulmonary/pleural infections /$rRichard G. Wunderink and Andrew M. Naldech -- $g20.$tVenous thromboembolism /$rKenneth V. Leeper, Jr. -- $g21.$tLung cancer /$rPeter I. Mazzone, Samuel T. Chao and John H. Suh -- $g22.$tSleep apnea syndromes and other sleep-related breathing disorders /$rGokhan M. Mutlu and Phyllis C. Zee -- $g23.$tNeurologic manifestations of interstitial lung disease /$rRobert P. Baughman and Istvan Pirko -- $g24.$tLung transplantation /$rWilliam D. Schweickert, Gregory Gruener and Edward R. Garrity, Jr. -- $g25.$tPharmacology of respiratory diseases /$rThomas C. Corbridge and Richard A. Bernstein -- $g26.$tAcute renal failure /$rVinod K. Bansal -- $g27.$tChronic renal failure /$rJoseph Mattana -- $g28.$tGlomerular diseases /$rSubhash Popli -- $g29.$tVascular diseases of the kidney /$rHitesh H. Shah and Brian Silver -- $g30.$tDialysis /$rJohn D. Wagner and Isabelle Korn-Lubetzki -- $g31.$tRenal transplantation /$rSusan H. Hou -- $g32.$tCommonly used renal drugs /$rVivekanand Jha -- $g33.$tEsophageal disorders and surgery /$rJoel M. Trugman, Colin C. Quinn and Hubert A. Shaffer, Jr. -- $g34.$tDiseases of the stomach and duodenum /$rWolfgang H. Jost and Volker F. Eckardt -- $g35.$tInflammatory bowel disease /$rRonald F. Pfeiffer and Fergus Shanahan -- $g36.$tNeurologic manifestations of gluten sensitivity /$rMarios Hadjivassillou and David S. Sanders -- $g37.$tDiseases of the pancreas /$rMichael Jacewicz and Christopher R. Marino -- $g38.$tNeurologic complications of gastrointestinal malignancies /$rMervat Wahba and John K. DiBaise -- $g39.$tBariatric surgery /$rBoyd M. Koffman and Isam Daboul -- $g40.$tGastrointestinal transplantation /$rJeffrey S. Kutcher and Fred K. Askari -- $g41.$tCommonly used gastrointestinal drugs /$rJohn C. Morgan, Brian W. Mitchell, Kapil D. Sethi and Robert R. Schade -- $g42.$tNeurological problems seen during the management of the patient with viral hepatitis /$rAnne Mai and Hugo E. Vargas -- $g43.$tManagement of acute liver failure : emphasis on neurologic complications /$rDavid J. Kramer and Benjamin H. Eidelman -- $g44.$tHepatic encephalopathy /$rAndres T. Blei and Karin Weissenborn -- $g45.$tLiver transplantation /$rSasa Zivkovic and Peter K. Linden -- $g46.$tCommonly used liver drugs /$rAndrew Silverman and David R. Chabolla -- $g47.$tRed blood cell disorders /$rHarry L. Messmore and William H. Wehrmacher -- $g48.$tDisorders of white blood cells /$rMichael Y. Ko and Harry L. Messmore -- $g49.$tDisorders of platelets /$rJoseph F. Stilwill, Mauna B. Pandya, Sucha Nand and Laura C. Michaelis -- $g50.$tSickle cell anemia and other hemoglobinopathies /$rMarry L. Messmore and William H. Wehrmacher -- $g51.$tBleeding diatheses and hemophilias /$rNirmala Bhoopalam, Chris Braden and Sowjanya Regantl -- $g52.$tThrombotic disorders /$rWilliam R. Brodcrick, Sucha Nand and Laura C. Michaells -- $g53.$tLymphoproliferative disorders /$rMichael Y. Ko and Harry L. Messmore -- $g54.$tPlasma cell disorders /$rGregory Grucner and Harry L. Messmore -- $g55.$tBone marrow transplantation /$rGregory Gruener and Harry L. Messmore -- $g56.$tCommonly used hematologic drugs /$rAthena Kostidis and Harry L. Messmore -- $g57.$tParaneoplastic disorders of the central nervous system /$rEdward J. Dropcho -- $g58.$tParaneoplastic disorders of the peripheral nervous system /$rEdward J. Dropcho -- $g59.$tRadiation therapy in neurologic disease /$rEdward Mclian -- $g60.$tChemotherapy /$rScow E. Smith -- $g61.$tDisorders of carbohydrate metabolism /$rRosarlo Maria S. Riel-Romero -- $g62.$tDisorders of lipoprotein metabolism /$rRosarlo Maria S. Riel-Romero -- $g63.$tDisorders of amino acid metabolism /$rRosario Maria S. Riel-Romero -- $g64.$tDisorders of the metabolism of purines and pyrimidines /$rRosario Maria S. Riel-Romero -- $g65.$tDisorders of porphyrins /$rAran A. Kalra and Roger E. Kelley -- $g66.$tDisorders of heavy metals /$rRoger E. Kelley and Jonathan Glass -- $g67.$tDisorders of bone and bone mineral metabolism /$rAran A. Kalra and Roger E. Kelley -- $g68.$tPaget disease of bone /$rRoger E. Kelley and Steven N. Levine -- $g69.$tNutritional deficiency syndromes /$rMartha P. Scagrave and Hrayr P. Attarian -- $g70.$tHydrosoluble vitamins (except B[subscript 12] and folate) /$rNoor A. Pirzada -- $g71.$tFat soluble vitamins /$rNancy Hammond and Yunxia Wang -- $g72.$tCobalamin (B[subscript 12]) deficiency /$rYunxia Wang, Carla Aamodt and Richard J. Barohn -- $g73.$tFolic acid deficiency /$rTaruna K. Aurora and Pawan Suri -- $g74.$tParenteral nutrition and neurologic complications /$rMarielle A. Kabbouche -- $g75.$tEnteral nutrition /$rLisa A. Millsap, Gretchen Peyton and Michael J. Schneck -- $g76.$tPituitary and hypothalamus /$rJorge C. Kattah and William C. Kattah -- $g77.$tThyroid dysfunction /$rJorge C. Kattah and William C. Kattah -- $g78.$tNeurologic complications of parathyroid gland disorders : hypoparathyroidism and hyperparathyroidism /$rMichael D. Sirdofsky and Leah Kroeger -- $g79.$tDisorders of the adrenal glands and neuroendocrine tumors /$rTullo E. Bertorini, Angel S. Perez and Maamoon Tammaa -- $g80.$tDiabetes mellitus /$rGregory M. Blume -- $g81.$tTestis and ovaries /$rCamilo E. Fadul -- $g82.$tMultiple endocrine syndromes /$rWilliam C. Kattah and Jorge C. Kattah -- $g83.$tCommonly used endocrine drugs /$rDaniel E. Jacome and Alfredo F. Jacome -- $g84.$tRheumatoid arthritis, spondyloarthropathies and relapsing polychondritis /$rMihaela Mihallescu, Steven U. Brint and William I. Swedler -- $g85.$tSystemic lupus erythematosus, Sjogren's syndrome, and scleroderma /$rJohn A. Robinson -- $g86.$tPrimary vasculitides and the nervous system /$rYair Molad and Jonathan Y. Streifler -- $g87.$tInflammatory myopathies /$rElizabeth G. Araujo -- $g88.$tHeritable connective tissue diseases /$rSilvina B. Tonarelli and Oscar Benavente -- $g89.$tSpinal stenosis /$rElaine M. Adams, Alexander J. Nemeth and Vijaya K. Patil -- $g90.$tBone tumors /$rTimothy B. Rapp -- $g91.$tCommonly used drugs (COX-2 inhibitors, NSAID, corticosteroids) /$rRodney Tehrani and Baltazar R. Espiritu -- $g92.$tBacterial meningitis /$rEdwin Swiatlo and Ethel S. Rose -- $g93.$tStroke complicating systemic and central nervous system infections /$rAugusto A. Miravalle, Jose Biller and James J. Corbett -- $g94.$tHiv/Aids /$rHarold Henderson -- $g95.$tFungal infections of the central nervous system /$rDorota Krezolek and Jaime Belmares-Avalos -- $g96.$tRickettsia /$rJohn E. Greenlee and DeVon C. Hale -- $g97.$tProtozoa and metazoa /$rAna-Claire L. Meyer and Glenn E. Mathisen -- $g98.$tSyphilis /$rJoseph R. Berger and Stephen Raffantl --
505 80 $g99.$tLyme disease /$rA. Arturo Leis and Stanley W. Chapman -- $g100.$tTuberculosis /$rMaria E. Santiago and Shehla P. Islam -- $g101.$tMalaria /$rGretchen L. Birbeck and Terrie E. Taylor -- $g102.$tOther topical infections /$rAna-Claire L. Meyer and Glenn E. Mathisen -- $g103.$tCommon antibiotics /$rRisa M. Webb -- $g104.$tOpiates /$rMichael A. Sloan -- $g105.$tAmphetamines and over-the-counter sympathomimetics /$rMichael A. Sloan -- $g106.$tCocaine /$rJohn Kashani -- $g107.$tHallucinogens /$rRobert Schwaner -- $g108.$tAlcohol /$rKathy L. Ferguson and Gar Ming Chan -- $g109.$tSolvents /$rWilliam J. Holubek -- $g110.$tMarijuana /$rDavid C. Lee -- $g111.$tPCP/ketamine /$rD. Adam Algren -- $g112.$tOther intoxicants /$rMichael C. Beuhler -- $g113.$tHypothermia /$rGalen V. Henderson -- $g114.$tHyperthermia /$rDeborah M. Green -- $g115.$tDisorders associated with diving, decompression, and gas bubbles /$rJames T. Boyd and Kenneth M. LeDez -- $g116.$tDrowning /$rMark Gorman -- $g117.$tCarbon monoxide poisoning /$rMonica Simionescu and Rima M. Dafer -- $g118.$tThe evaluation and management of lightning injuries /$rBruce Crookes -- $g119.$tHigh altitude illness /$rAdam D. Quick -- $g120.$tCiguatera poisoning /$rHrayr P. Attarian -- $g121.$tVenomous snakebites in the US /$rChristopher Commichau -- $g122.$tSkin neoplasms /$rBetsy B. Love and Charles W. Love -- $g123.$tPhakodermatoses and other genetic conditions with dermatologic manifestations /$rTerrence M. Brogan, Beth L. Brogan and Robert M. Pascuzzi -- $g124.$tNeuro-dermatological presentations of systemic illness /$rLawrence A. Mark and James D. Fleck -- $g125.$tCommonly used dermatological drugs /$rTerrence M. Brogan and Beth L. Brogan -- $g126.$tComa (non-traumatic) and brain death /$rMichael J. Schneck and Vikram C. Prabhu -- $g127.$tShock /$rAnkush Gosain and Fred A. Luchette -- $g128.$tSepsis /$rJohn M. Santantello -- $g129.$tMechanical ventilation /$rBruce Kleinman and Kere Frey -- $g130.$tAcid-base disorders /$rCarol R. Schermer and Ellen C. Omi -- $g131.$tFluid and electrolyte disorders /$rAnkush Gosain and Fred A. Luchette -- $g132.$tHemodynamic control : pressors and antihypertensive agents /$rMichael H. Whiteley and W. Scott Jellish -- $g133.$tSedation and analgesia in the neurological intensive care unit /$rSteven B. Edelstein and Kurt Baker-Watson -- $g134.$tCritical illness polyneuropathy and myopathy /$rJasvinder P. S. Chawla -- $g135.$tICU psychosis /$rHarold W. Goforth and Murali S. Rao -- $g136.$tOrbital diseases /$rMichael P. Merchut and Amjad Ahmad -- $g137.$tOcular infections and inflammation /$rAnuradha Khanna and Michael P. Merchut -- $g138.$tOptic neuritis and retinal vascular disorders /$rFelipe De Alba and Michael P. Merchut -- $g139.$tHead, neck, and skull base neoplasms /$rChad Zender, Sam J. Marzo, John P. Leonetti, Athena Kostidis and Rima M. Dafer -- $g140.$tENT infections and inflammation /$rJoseph M. Scianna, James A. Stankiewicz and Adriana Rodriguez Quinonez -- $g141.$tVertigo /$rRita Schuman, Sam J. Marzo, John P. Leonetti, Athena Kostidis and Rima M. Dafer -- $g142.$tPreeclampsia and eclampsia /$rJohn G. Glanopoulos -- $g143.$tHeadaches in pregnancy /$rRichard E. Besinger and Robert M. Abrams -- $g144.$tEpilepsy in pregnancy /$rJorge J. Asconape -- $g145.$tTeratogenicity of antiepileptic drugs /$rJorge J. Asconape -- $g146.$tPregnancy-related neuropathies /$rJasvinder P. S. Chawla -- $g147.$tMovement disorders in pregnancy /$rFederico E. Michell -- $g148.$tDiphtheria /$rWendy L. Hobson-Rohrer and James F. Bale, Jr. -- $g149.$tPertussis /$rApril E. Kilgore and Charlotte T. Jones -- $g150.$tMeasles /$rHannah Klein de Licona and Daniel J. Bonthius -- $g151.$tMumps /$rWendy L. Hobson-Rohrer and James F. Bale, Jr. -- $g152.$tRubella /$rAmanda Snodgrass and Charlotte T. Jones -- $g153.$tVaricella-zoster infections /$rDaniel J. Bonthius and Charles Grose -- $g154.$tErythema infectiosum (fifth disease) /$rDaniel J. Bonthius and Bahri Karacay -- $g155.$tNeurologic complications of Henoch-Schonlein purpura /$rWilliam E. Bell and Jacob A. Lohr -- $g156.$tNeurologic complications of the hemolytic uremic syndrome /$rWilliam E. Bell and Jacob A. Lohr -- $g157.$tNonaccidental head trauma in infants : the "shaken baby syndrome" /$rPaula Gerber, Kathryn A. Coffman and John B. Bodenstetner -- $g158.$tNeurologic complications of cystic fibrosis /$rWilliam E. Bell and Jacob A. Lohr -- $g159.$tNeurologic consequences of vaccines in children /$rLeslie Allen and Charlotte T. Jones -- $g160.$tAcute radiation syndrome /$rGuillermo Linares-Tapia and J. Javier Provencio -- $g161.$tNerve agents /$rChristopher P. Holstege and Sarice L. Bassin -- $g162.$tBotulinum toxin /$rAndreas H. Kramer and Vern C. Juel -- $g163.$tCyanide /$rMark A. Kirk and Jeffery J. Fletcher -- $g164.$tSmallpox /$rRichard A. Zuckerman and Barnett R. Nathan -- $g165.$tDepression and neurology /$rRichard Wolin, Steven L. Dubovsky and Richard Cowan -- $g166.$tThe anxiety disorders : clinical presentation, diagnosis, treatment, and beyond /$rAbigail L. Donovan, Joshua L. Roffman, Dan V. Iosifescu, Jeremiah M. Scharf and Theodore A. Stern -- $g167.$tDelirium /$rBenjamln Liptzin, Steven V. Fischel and Sheldon Benjamin -- $g168.$tSomatoform disorders /$rThomas N. Wise and James R. Merikangas -- $g169.$tSuicide risk assessment /$rHoward S. Sudak -- $g170.$tCommonly used psychotropic medications /$rAlexander W. Thompson, Dan Major and Glenn Treisman -- $g171.$tCommonly used drugs in the neurology realm /$rRoger E. Kelley.
650 0 $aNervous system$xDiseases.$0http://id.loc.gov/authorities/subjects/sh85090924
650 0 $aNeurologic manifestations of general diseases.$0http://id.loc.gov/authorities/subjects/sh85091132
650 0 $aInternal medicine.$0http://id.loc.gov/authorities/subjects/sh85067347
650 12 $aNeurologic Manifestations.$0https://id.nlm.nih.gov/mesh/D009461
650 22 $aInternal Medicine.$0https://id.nlm.nih.gov/mesh/D007388
700 1 $aBiller, José.$0http://id.loc.gov/authorities/names/n85024510
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0719/2007022710.html
852 00 $boff,hsl$hRC346$i.I53 2008 Q